ID   PSU-SK-1
AC   CVCL_IU86
DR   Cosmic; 2569715
DR   Wikidata; Q54948616
RX   PubMed=27698927;
CC   Senescence: Senesces at 35 PDL (PubMed=27698927).
CC   Doubling time: 24 hours (Note=At 7th passage), 72 hours (Note=At 30th passage) (PubMed=27698927).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Pro (c.133T>C); ClinVar=VCV000017589; Zygosity=Unspecified (PubMed=27698927).
CC   Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Arg433Ter (c.1297C>T) (R413*) (R430*); Zygosity=Unspecified (PubMed=27698927).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C40407; Kidney Wilms tumor
DI   NCIt; C3718; Wilms tumor-aniridia-genitourinary anomalies-mental retardation syndrome
DI   ORDO; Orphanet_654; Nephroblastoma
DI   ORDO; Orphanet_893; WAGR syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Finite cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 14
//
RX   PubMed=27698927; DOI=10.7150/jca.16316; PMCID=PMC5039371;
RA   Theerakitthanakul K., Kruatong J., Kruatong J., Graidist P.,
RA   Raungrut P., Kayasut K., Sangkhathat S.;
RT   "Senescence process in primary Wilms' tumor cell culture induced by
RT   p53 independent p21 expression.";
RL   J. Cancer 7:1867-1876(2016).
//